Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma

E. P. Balaban, B. S. Walker, J. V. Cox, A. A. Tin Sein, P. G. Abrams, D. Salk, R. G. Sheehan, E. P. Frenkel

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The detection of metastatic disease confined to the bone marrow compartment has in the past been technically limited. We have identified excellent imaging of bone marrow metastases during the evaluation of a Tc-99m labeled monoclonal antibody (NR-LU-10 Fab) (NeoRx Corp., Seattle, WA). This occurred during a study to assess the monoclonal antibody's ability to detect sites of small cell cancer (primary and metastatic). The study by design compares areas seen by the monoclonal antibody scan with those found by standard staging methods in patients with small cell lung cancer. Standard staging included chest x-rays, bone scans, CT studies of the abdomen, and histologic examination of the bone marrow. Fifteen patients have been evaluated, four on two occasions, for a total of 19 monoclonal imaging studies. Metastasis to the marrow compartment was identified by the monoclonal imaging in all patients whose bone marrow biopsies were positive for small cell carcinoma, and it was primarily responsible for the eventual detection of extensive disease (marrow involvement) in one patient. Thus it appears that compartmental bone marrow imaging for metastatic disease is possible with immunoscintigraphy.

Original languageEnglish (US)
Pages (from-to)732-736
Number of pages5
JournalClinical Nuclear Medicine
Volume16
Issue number10
StatePublished - 1991

Fingerprint

Small Cell Lung Carcinoma
Radionuclide Imaging
Bone Marrow
Monoclonal Antibodies
Neoplasm Metastasis
Bone Marrow Examination
Small Cell Carcinoma
Abdomen
Thorax
X-Rays
Biopsy
Bone and Bones
Neoplasms

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Balaban, E. P., Walker, B. S., Cox, J. V., Tin Sein, A. A., Abrams, P. G., Salk, D., ... Frenkel, E. P. (1991). Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma. Clinical Nuclear Medicine, 16(10), 732-736.

Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma. / Balaban, E. P.; Walker, B. S.; Cox, J. V.; Tin Sein, A. A.; Abrams, P. G.; Salk, D.; Sheehan, R. G.; Frenkel, E. P.

In: Clinical Nuclear Medicine, Vol. 16, No. 10, 1991, p. 732-736.

Research output: Contribution to journalArticle

Balaban, EP, Walker, BS, Cox, JV, Tin Sein, AA, Abrams, PG, Salk, D, Sheehan, RG & Frenkel, EP 1991, 'Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma', Clinical Nuclear Medicine, vol. 16, no. 10, pp. 732-736.
Balaban, E. P. ; Walker, B. S. ; Cox, J. V. ; Tin Sein, A. A. ; Abrams, P. G. ; Salk, D. ; Sheehan, R. G. ; Frenkel, E. P. / Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma. In: Clinical Nuclear Medicine. 1991 ; Vol. 16, No. 10. pp. 732-736.
@article{e5633b6e4a504201b5c8b432441bfa0e,
title = "Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma",
abstract = "The detection of metastatic disease confined to the bone marrow compartment has in the past been technically limited. We have identified excellent imaging of bone marrow metastases during the evaluation of a Tc-99m labeled monoclonal antibody (NR-LU-10 Fab) (NeoRx Corp., Seattle, WA). This occurred during a study to assess the monoclonal antibody's ability to detect sites of small cell cancer (primary and metastatic). The study by design compares areas seen by the monoclonal antibody scan with those found by standard staging methods in patients with small cell lung cancer. Standard staging included chest x-rays, bone scans, CT studies of the abdomen, and histologic examination of the bone marrow. Fifteen patients have been evaluated, four on two occasions, for a total of 19 monoclonal imaging studies. Metastasis to the marrow compartment was identified by the monoclonal imaging in all patients whose bone marrow biopsies were positive for small cell carcinoma, and it was primarily responsible for the eventual detection of extensive disease (marrow involvement) in one patient. Thus it appears that compartmental bone marrow imaging for metastatic disease is possible with immunoscintigraphy.",
author = "Balaban, {E. P.} and Walker, {B. S.} and Cox, {J. V.} and {Tin Sein}, {A. A.} and Abrams, {P. G.} and D. Salk and Sheehan, {R. G.} and Frenkel, {E. P.}",
year = "1991",
language = "English (US)",
volume = "16",
pages = "732--736",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma

AU - Balaban, E. P.

AU - Walker, B. S.

AU - Cox, J. V.

AU - Tin Sein, A. A.

AU - Abrams, P. G.

AU - Salk, D.

AU - Sheehan, R. G.

AU - Frenkel, E. P.

PY - 1991

Y1 - 1991

N2 - The detection of metastatic disease confined to the bone marrow compartment has in the past been technically limited. We have identified excellent imaging of bone marrow metastases during the evaluation of a Tc-99m labeled monoclonal antibody (NR-LU-10 Fab) (NeoRx Corp., Seattle, WA). This occurred during a study to assess the monoclonal antibody's ability to detect sites of small cell cancer (primary and metastatic). The study by design compares areas seen by the monoclonal antibody scan with those found by standard staging methods in patients with small cell lung cancer. Standard staging included chest x-rays, bone scans, CT studies of the abdomen, and histologic examination of the bone marrow. Fifteen patients have been evaluated, four on two occasions, for a total of 19 monoclonal imaging studies. Metastasis to the marrow compartment was identified by the monoclonal imaging in all patients whose bone marrow biopsies were positive for small cell carcinoma, and it was primarily responsible for the eventual detection of extensive disease (marrow involvement) in one patient. Thus it appears that compartmental bone marrow imaging for metastatic disease is possible with immunoscintigraphy.

AB - The detection of metastatic disease confined to the bone marrow compartment has in the past been technically limited. We have identified excellent imaging of bone marrow metastases during the evaluation of a Tc-99m labeled monoclonal antibody (NR-LU-10 Fab) (NeoRx Corp., Seattle, WA). This occurred during a study to assess the monoclonal antibody's ability to detect sites of small cell cancer (primary and metastatic). The study by design compares areas seen by the monoclonal antibody scan with those found by standard staging methods in patients with small cell lung cancer. Standard staging included chest x-rays, bone scans, CT studies of the abdomen, and histologic examination of the bone marrow. Fifteen patients have been evaluated, four on two occasions, for a total of 19 monoclonal imaging studies. Metastasis to the marrow compartment was identified by the monoclonal imaging in all patients whose bone marrow biopsies were positive for small cell carcinoma, and it was primarily responsible for the eventual detection of extensive disease (marrow involvement) in one patient. Thus it appears that compartmental bone marrow imaging for metastatic disease is possible with immunoscintigraphy.

UR - http://www.scopus.com/inward/record.url?scp=0026014183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026014183&partnerID=8YFLogxK

M3 - Article

C2 - 1660386

AN - SCOPUS:0026014183

VL - 16

SP - 732

EP - 736

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 10

ER -